4-MTA
4-MTA (4-methylthioamphetamine) is a particularly dangerous amphetamine-type serotonin releaser that also inhibits monoamine oxidase. It causes massive, poorly controlled serotonin release and has been directly implicated in multiple deaths. It is not a safe MDMA substitute and is described here as a hazard, not a recreational option.
01 Overview
4-MTA (4-methylthioamphetamine, 'flatliner') is a ring-substituted amphetamine that both releases serotonin and acts as a reversible monoamine oxidase inhibitor. This combination floods synapses with serotonin while blocking its breakdown, an unusually dangerous mechanism.
A slow onset led users to redose, precipitating severe, sometimes fatal serotonin toxicity and hyperthermia. Several deaths in the late 1990s and early 2000s were attributed to 4-MTA, prompting international control. It is stated plainly here: 4-MTA is exceptionally hazardous, with a narrow margin between an active dose and life-threatening toxicity.
02 Mechanism
Potent serotonin-releasing agent combined with monoamine oxidase A inhibition, producing sustained, poorly controlled serotonin excess. The MAOI action makes serotonin syndrome and hyperthermia far more likely than with MDMA.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Threshold / hazard | 20–40 mg | Oral | No safe dose is established; the toxic margin is narrow and deaths have occurred at recreational doses. |
| Reported (hazardous) | 40–80 mg | Oral | Slow onset drove fatal redosing. This range is documented, not endorsed. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Delayed, weak empathySlow-onset, muted MDMA-like effects that historically led users to dangerously redose. | Anecdotal | ||
| Mild stimulationModest stimulant effect disproportionate to the severe toxicity risk. | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Fatal serotonin syndromeThe combined releaser/MAOI action has caused fatal serotonin toxicity - hyperthermia, seizures, DIC and multi-organ failure - documented in multiple deaths. | Life-threatening | A defining, common hazard of this compound | Observational | |
| Severe hyperthermiaExtreme, refractory hyperthermia documented in fatal cases. | Life-threatening | Common in intoxications | Observational | |
| Cardiovascular collapseSevere hypertension and cardiovascular instability contributing to death. | Life-threatening | Uncommon but reported in fatalities | Observational |